Home / People / Dr. Thomas Hirse
Portrait of Thomas Hirse

Dr. Thomas Hirse

Partner
Rechtsanwalt

CMS Hasche Sigle
Kasernenstraße 43-45
40213 Duesseldorf
Germany
Languages German, English

Thomas Hirse has extensive experience in patent and utility model law, including all related antitrust law aspects and questions related to employee inventions. In addition, he is specialized on trade secret protection and data protection law specific for life sciences and medical devices companies.

He regularly advises on technology-driven mergers and acquisitions as well as patent litigation matters particularly in the life sciences and medical devices sector as well as plant engineering and construction industry. He has extensive experience with the legal evaluation and enforcement of intellectual property, including development of IP protection concepts and strategy. Additionally, Thomas successfully drafted and negotiated numerous complex R&D and license agreements and handled IP-related issues in R&D and licensing collaborations for his clients, including related competition law and public funding and subsidy law aspects.

Thomas advises and represents clients in national and international patent disputes with respect to both enforcement of their patents and the defense of patent infringement actions, including representation in opposition, invalidation and cancellation proceedings. He regularly provides patent FTO-analyses.

He started his legal career with Linklaters in 2006, joined CMS in 2007 and was seconded to Bayer in 2010 and a global specialty chemical enterprise in 2013. He has been a partner since 2014.

Thomas is member of GRUR, LES, AIPLA, EPLAW, the Advisory Board of the Research Alliance Leibniz Health Technologies, Co-Head of the working group "IP and technology agreements" and active member of the working group "Technology transfer" of the German biotech association BIO Deutschland e.V.

more less

Publications

  • Schriftenreihe des Max-Planck-Instituts für auslaendisches und internationales Privatrecht, Die Ausweichklausel im Internationalen Privatrecht - Methodentheoretische und -kritische Gedanken zu einer besonderen kollisionsrechtlichen Generalklausel, Mohr Siebeck Tübingen 2007
  • Kothe/Micklitz/Rott/Tonner/Willingmann; Das neue Schuldrecht - Kompaktkommentar, Kommentierung der Regelungen zum Leistungsstoerungs-und Ruecktrittsfolgenrecht, Luchterhand 2003
  • Beitraege zur Neuregelung des Leistungsstoerungsrechts im Rahmen der Schuldrechtsmodernisierung, VuR 2001, p. 99 ff
  • Die Prozessfuehrung durch den Versicherer (zus. mit Prof. Dr. Harald Koch), VersR 2001
  • Anmerkungen und Beitraege zu verschiedenen BGH-Entscheidungen zum Folgekostenstreit bei straßenbaubedingter Verlegung von Versorgungsleitungen in den neuen Bundeslaendern, NJ 2001, p. 459 ff
more less

Education

  • 2005: PhD; thesis on international private law
  • 2003 - 2005: Trainee lawyer at Wuppertal Regional Court
  • 2001 - 2002: Friedrich Naumann Foundation PhD scholar
  • 2001 - 2002: Worked as legal expert for Arbeitsgemeinschaft der Verbraucherverbände e.V. in the context of the legislative process for the reform of the German law of obligations
  • 2000 - 2002: Research assistant to a Higher Regional Court judge and to Prof. Dr. Harald Koch, Chair for Civil Law, Civil Procedure Law, International Private Law and Comparative Law
  • 1995 - 2000: Law studies at the University of Rostock
more less

Feed

25/01/2023
CMS Green Globe | New coun­try ad­ded!
Stay in­formed about the latest sus­tain­ab­il­ity claims trends and de­vel­op­ments CMS Green Globe is an in­ter­act­ive plat­form that al­lows busi­nesses and cli­ents to stay aware and duly in­formed about all the main rap­idly chan­ging trends and de­vel­op­ments re­lated to sus­tain­ab­il­ity claims across the world.Here you will find in­form­a­tion on reg­u­la­tion and de­vel­op­ments you need to know when ad­vert­ising and mar­ket­ing your busi­ness or product by us­ing sus­tain­ab­il­ity claims as well as our key ex­perts to sup­port you in nav­ig­at­ing the world of such claims.CMS Green Globe helps you to avoid gre­en­wash­ing your con­sumer in your jur­is­dic­tion as well as across the globe. Dis­cov­er CMS Green Globe Best ex­plored on desktop
20/01/2023
CMS ad­vises US tech­no­logy com­pany Bruker on ac­quis­i­tion of AC­QUIFER
Frank­furt/Main – Bruker Cor­por­a­tion, a NAS­DAQ-lis­ted US tech com­pany, has ac­quired AC­QUIFER, a joint ven­ture between AC­QUIFER Ima­ging GmbH and Delta­byte GmbH, which are both based in Heidel­berg. AC­QUIFER...
16/01/2023
CMS ad­vises Pinova on ac­quis­i­tion of VTI Vent­il Tech­nik GmbH
Frank­furt/Main – Funds ad­vised by in­de­pend­ent private equity firm Pinova Cap­it­al GmbH have ac­quired a ma­jor­ity stake in VTI Vent­il Tech­nik GmbH to­geth­er with NRW.BANK. The seller is the AMX-lis­ted Aal­berts...
04/01/2023
CMS ad­vises US tech­no­logy com­pany Bruker on en­ter­ing in­to equity-based...
Frank­furt/Main – Bruker Cor­por­a­tion, a NAS­DAQ-lis­ted US tech com­pany, has entered in­to a part­ner­ship with Swiss firm Biognosys AG to de­liv­er ad­vanced pro­teo­m­ics CRO ser­vices for US bio­pharma and bio­mark­er...
15/11/2022
Ex­pan­sion of EMS busi­ness: CMS ad­vises Swiss elec­tron­ics in­dustry com­pany...
Frank­furt/Main – The Cicor Group (SIX Swiss Ex­change: CICN), which is headquartered in Bron­sch­hofen, Switzer­land, has ac­quired the Ger­man and Tunisi­an elec­tron­ic man­u­fac­tur­ing ser­vices (EMS) busi­ness...
22/09/2022
CMS ad­vises found­ing share­hold­ers of me­dav­is Group on sale to Bregal Un­ternehmerkapit­al
Frank­furt/Main – Funds ad­vised by Bregal Un­ternehmerkapit­al (BU Funds) have ac­quired a ma­jor­ity stake in the me­dav­is Group, a lead­ing de­veloper of work­flow soft­ware for ra­di­ology ser­vices in Ger­many...
16/09/2022
CMS ad­vises in­ter­na­tion­al auto­mot­ive sup­pli­er Webasto on ac­quis­i­tion of...
Co­logne – Webasto Roof & Com­pon­ents SE, a glob­al auto­mot­ive sup­pli­er based in Stock­dorf near Mu­nich, has in­dir­ectly ac­quired all the shares in Car­lex Glass Lux­em­bourg S.A. by pur­chas­ing all the shares...
29/09/2022
Glob­al LSHC For­um 2022
Un­cer­tain times, an evolving leg­al frame­work: man­aging risks and en­sur­ing so­cial re­spons­ib­il­ity in the life sci­ences & health­care sec­tor
26/07/2022
CMS Ex­pert Guide on Bolar Pro­vi­sions
In­tro­duc­tion Bolar pro­vi­sions, named after the US law en­acted to over­turn a court rul­ing which had held that the USA did not provide for a re­search ex­emp­tion (see Roche Products, Inc. v. Bolar Phar­ma­ceut­ic­al...
Comparable
29/09/2022
Glob­al Life Sci­ences & Health­care For­um 2022
Un­cer­tain times, an evolving leg­al frame­work: man­aging risks and en­sur­ing so­cial re­spons­ib­il­ity in the life sci­ences & health­care sec­tor
03/06/2022
CMS ad­vises SaaS pro­vider F24 on ac­quis­i­tion of Busi­ness-DNA Solu­tions
Frank­furt/Main – F24 AG has ac­quired Swiss com­pany Busi­ness-DNA Solu­tions GmbH, a pro­vider of ad­vanced solu­tions for gov­ernance, risk and com­pli­ance in Ger­many, Aus­tria and Switzer­land. F24 de­scribes...
11/05/2022
CMS ad­vises US tech­no­logy com­pany Bruker on in­vest­ment in Tofwerk
Frank­furt/Main – Bruker Cor­por­a­tion, a NAS­DAQ-lis­ted US tech com­pany in the ana­lyt­ic­al in­stru­ment­a­tion sec­tor, has ac­quired a stake in Swiss firm Tofwerk AG. Tofwerk de­vel­ops time-of-flight mass spec­tro­met­ers...